Proton Pump Inhibitors Raise Persistent Diarrhea Risk, Warns FDA
Stomach acid drugs, known as PPIs (proton pump inhibitors), are linked to a higher risk of diarrhea caused by Clostridium difficile, a type of bacterium. Patients on PPIs who develop persistent diarrhea should be tested for CDAD (Clostridium difficile associated diarrhea), says the US Food and Drug Administration (FDA). If you are taking PPIs, and have diarrhea that does not go away, you should ...

ADDING MULTIMEDIA FDA Approves KALYDECO (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic ...
Vertex Pharmaceuticals Incorporated announced today that the U.S. Food and Drug Administration has approved KALYDECOTM , the first medicine to treat the underlying cause of cystic fibrosis , a rare, genetic disease.